Tandem Capital Management Corp ADV Raises Stock Position in Colfax Co. (NYSE:CFX)

Tandem Capital Management Corp ADV boosted its position in shares of Colfax Co. (NYSE:CFX) by 1.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,740 shares of the industrial products company’s stock after acquiring an additional 750 shares during the period. Colfax accounts for about 1.4% of Tandem Capital Management Corp ADV’s holdings, making the stock its 28th biggest position. Tandem Capital Management Corp ADV’s holdings in Colfax were worth $2,091,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the business. Bragg Financial Advisors Inc grew its stake in Colfax by 1.3% in the 4th quarter. Bragg Financial Advisors Inc now owns 31,385 shares of the industrial products company’s stock worth $1,200,000 after buying an additional 404 shares in the last quarter. The PNC Financial Services Group Inc. lifted its holdings in shares of Colfax by 5.0% in the 1st quarter. The PNC Financial Services Group Inc. now owns 8,584 shares of the industrial products company’s stock worth $377,000 after acquiring an additional 409 shares during the last quarter. Carroll Financial Associates Inc. lifted its holdings in shares of Colfax by 151.4% in the 1st quarter. Carroll Financial Associates Inc. now owns 729 shares of the industrial products company’s stock worth $31,000 after acquiring an additional 439 shares during the last quarter. Panagora Asset Management Inc. lifted its holdings in shares of Colfax by 6.9% in the 1st quarter. Panagora Asset Management Inc. now owns 10,368 shares of the industrial products company’s stock worth $454,000 after acquiring an additional 668 shares during the last quarter. Finally, People s United Financial Inc. lifted its holdings in shares of Colfax by 3.7% in the 4th quarter. People s United Financial Inc. now owns 19,590 shares of the industrial products company’s stock worth $749,000 after acquiring an additional 698 shares during the last quarter. 96.50% of the stock is owned by institutional investors and hedge funds.

A number of equities research analysts have recently weighed in on the stock. Barclays restated an “underweight” rating and issued a $45.00 price objective (down from $48.00) on shares of Colfax in a report on Tuesday, April 13th. Morgan Stanley upped their price target on shares of Colfax from $45.00 to $47.00 and gave the company an “equal weight” rating in a report on Friday, April 30th. Citigroup upped their price target on shares of Colfax from $35.00 to $41.00 in a report on Monday, February 22nd. KeyCorp upped their price target on shares of Colfax from $47.00 to $57.00 and gave the company an “overweight” rating in a report on Friday, March 12th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Colfax from $53.00 to $54.00 and gave the company a “hold” rating in a report on Friday, March 12th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $42.45.

In other news, CEO Matthew L. Trerotola sold 200,000 shares of the business’s stock in a transaction dated Friday, May 14th. The stock was sold at an average price of $43.14, for a total transaction of $8,628,000.00. Following the sale, the chief executive officer now owns 505,708 shares in the company, valued at $21,816,243.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Patricia A. Lang sold 24,677 shares of the company’s stock in a transaction that occurred on Monday, May 3rd. The shares were sold at an average price of $43.94, for a total value of $1,084,307.38. Following the completion of the sale, the senior vice president now owns 43,218 shares in the company, valued at approximately $1,898,998.92. The disclosure for this sale can be found here. 9.60% of the stock is owned by insiders.

Shares of NYSE:CFX traded up $0.34 during trading on Friday, hitting $46.28. The company’s stock had a trading volume of 5,711 shares, compared to its average volume of 1,429,821. The company has a 50-day simple moving average of $44.18. Colfax Co. has a 12 month low of $24.70 and a 12 month high of $50.26. The company has a current ratio of 1.33, a quick ratio of 0.94 and a debt-to-equity ratio of 0.35. The firm has a market cap of $6.28 billion, a price-to-earnings ratio of 112.05, a price-to-earnings-growth ratio of 1.00 and a beta of 2.21.

Colfax (NYSE:CFX) last announced its quarterly earnings data on Thursday, April 29th. The industrial products company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.05. Colfax had a net margin of 1.83% and a return on equity of 5.49%. The business had revenue of $879.21 million during the quarter, compared to analyst estimates of $841.42 million. On average, equities research analysts forecast that Colfax Co. will post 2.14 EPS for the current year.

Colfax Profile

Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment.

See Also: Float

Want to see what other hedge funds are holding CFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colfax Co. (NYSE:CFX).

Institutional Ownership by Quarter for Colfax (NYSE:CFX)

Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.